品牌咨询
联系方式
公司地址
苏州工业园区生物纳米园A4#216
联系电话
4000-520-616 / 18915418616
传真号码
0512-67156496
电子邮箱
info@ebiomall.com
公司网址
https://www.ebiomall.com

Relia Tech/Rat Anti-Mouse VEGFR-2/FLK-1/100 µg/103-M35A

价格
¥5500.00
货号:103-M35A
浏览量:55
品牌:Relia Tech
服务
全国联保
正品保证
正规发票
签订合同
商品描述
Cat-Nr.103-M35A
Size100 µg
Price275 €
CategoryMonoclonal Antibody
Clone Nr.(#6C23)
IsotypeIgG2a
Species ReactivityMouse
Formulationlyophilized
BufferPBS
ReconstitutionCentrifuge vial prior to opening. Reconstitute the antibody with 500 µl sterile PBS and the final concentration is 200 µg/ml.
Stability and StorageLyophilized samples are stable for 2 years from date of receipt when stored at -20°C. Reconstituted antibody can be aliquoted and stored frozen at < -20°C for at least six months without detectable loss of activity.
PreparationThis antibody was produced from a hybridoma (mouse myeloma fused with spleen cells from a mouse) immunized with mouse VEGFR-2 extracellular domain. IgG2a fraction of the tissue culture supernatant was purified by Protein G affinity chromatography.
AntigenMouse VEGFR2 extra-cellular domain
ApplicationWB, IHC (P)
Synonymsvascular endothelial growth factor receptor-2 ; Kdr; Ly73; Flk-1; VEGF receptor 2; kinase insert domain protein receptor
DescriptionVEGF R1 (Flt-1), VEGF R2 (KDR/Flk-1), and VEGF R3 (Flt-4) belong to the class III subfamily of receptor tyrosine kinases (RTKs). All three receptors contain seven immunoglobulin-like repeats in their extracellular domain and kinase insert domains in their intracellular region. They are best known for regulating VEGF family-mediated vasculogenesis, angiogenesis, and lymphangiogenesis. They are also mediators of neurotrophic activity and regulators of hematopoietic development. VEGF R2 is thought to be the primary inducer of VEGF-mediated blood vessel growth, while VEGF R3 plays a significant role in VEGF-C and VEGF-D-mediated lymphangiogenesis.
Uniprot IDP35918
Protein RefSeqACJ66293.1
mRNA RefSeqEU884114
Relia Tech类似于我们在大肠杆菌中的蛋白质表达服务,我们还提供了围绕昆虫细胞中基因和蛋白质表达(尤其是信号蛋白质)的模块化服务系统。ReliaTech的“杆状病毒表达服务(BVS)”分为一系列步骤,这些步骤可以单独执行或组合执行,因此您可以选择实际需要的步骤。这些服务旨在充分满足从基因表达到蛋白质纯化的所有特定需求-从通过重组杆状病毒构建,高滴度重组杆状病毒生产,重组蛋白批量生产以及最终蛋白质纯化的基因克隆到杆状病毒转移载体开始。所有步骤均在无血清培养基中进行,以确保安全性并产生高纯度的重组蛋白。除常规项目更新外,您还将在每个服务步骤的最后收到进度报告。我们将根据您的授权逐步指导您继续进行。